Ralph T. Doyle, Jr., BA

Executive Director
Amarin Pharma, Inc.

Poster(s):

• (P238) ICOSAPENT ETHYL REDUCES MACE IN PATIENTS WITH ELEVATED TRIGLYCERIDES AND HIGH OR LOW LIPOPROTEIN(A) CONCENTRATIONS: A REDUCE-IT SUBANALYSIS
  Friday, October 25, 2024

  1:30 PM – 2:00 PM PT